MetLife price target lowered to $82 from $85 at Piper Sandler

Piper Sandler analyst John Barnidge lowered the firm’s price target on MetLife to $82 from $85 and keeps an Overweight rating on the shares following quarterly results. The firm notes Higher Group Benefits claims experience from a return to seasonably of dental and a few large claims elsewhere has been an industry theme this earnings season. The company’s earnings ex-this impact were in-line with its expectations illustrating the natural hedge of MetLife’s portfolio of businesses approach globally, adds Piper.